Abstract
Macrophages play a pivotal role at all stages of progression of atherosclerosis. However, the macrophage-targeted treatment of atherosclerosis remains elusive. Recently, macrophage-targeted gene therapy via lipid polymer nanoparticles (NPs) to improve the atherosclerotic plaque stability in mice was reported.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
